🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Eosinophilic Esophagitis: Towards Improved Management

Recruitingn/aAges any - 17 YearsAllOslo University Hospital
NCT06991881 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The current project aims to improve the care for children and adolescents with eosinophilic esophagitis in a collaborative effort involving pediatric units at Oslo Unversity Hospital and Helse Bergen, Norway. Existing and new non-invasive biomarkers will be explored systematically, aiming to reduce the number of endoscopies and time on restricted diet.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * a diagnosis of eosinophilic esophagitis * suspected but not yet confirmed eosinophilic esophagitis Exclusion Criteria: * chronic severe conditions that preclude general anaestesia * lack of consent
💊

What it tests

  • Biobank sampling for new biomarkers
📍

Where

2 sites
Haukeland University Hospital
Bergen, Norway
OsloUH
Oslo, Norway
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy